Vetherapy® - Veterinary Regenerative Medicine logo — Vetherapy uses stem cells, PRP, and biomaterials to create e...

Vetherapy® - Veterinary Regenerative Medicine

Vetherapy uses stem cells, PRP, and biomaterials to create effective veterinary regenerative medicine products.

Founded 2015 United States United States 2 employees Grant Total: $71.43K Biotechnology

General Information

Company Name Vetherapy® - Veterinary Regenerative Medicine
Founded Year 2015
Location United States United States
Founders / Decision Makers
Team member Team member Team member
Employees 2
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Vetherapy® - Veterinary Regenerative Medicine. To contact Vetherapy® - Veterinary Regenerative Medicine, visit vetherapy.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vetherapy® - Veterinary Regenerative Medicine compare?

A PDF of Vetherapy® - Veterinary Regenerative Medicine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vetherapy® - Veterinary Regenerative Medicine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vetherapy® - Veterinary Regenerative Medicine

Vetherapy is a biotech startup founded in 2015 with its headquarters in the United States. The company focuses on Veterinary Regenerative Medicine, utilizing stem cells, platelet-rich plasma (PRP), and biomaterials to create effective therapeutic products for animals through Tissue Engineering. In January 2019, Vetherapy secured a €71.43K grant investment from EASME - EU Executive Agency for SMEs. This investment serves as a validation of Vetherapy's innovative approach to animal health and positions the company for further growth and development within the biotech industry. Vetherapy's focus on regenerative medicine presents an opportunity to address unmet medical needs in the veterinary space, potentially offering significant health benefits to animals. With the backing of the EU Executive Agency for SMEs, Vetherapy demonstrates the potential to make a meaningful impact in the field of veterinary medicine.

Business keywords: veterinary medicine, regenerative medicine, biotech, stem cells, tissue engineering, animal health, biomaterials, PRP, animal therapy, veterinary products

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Seed Round Undisclosed 2
SOSV, indiebio
22 Jan 2018

Vetherapy® - Veterinary Regenerative Medicine Alternatives & Competitors

View All Alternatives
Vetherapy® - Veterinary Regenerative Medicine vs

Leading Animal Cell Therapy - Improving Animal Healthcare.

Venture round
11 employees
Biotechnology
Vetherapy® - Veterinary Regenerative Medicine vs

Měníme klasické paradigma léčby

4 employees
Biotechnology, Health Care
Vetherapy® - Veterinary Regenerative Medicine vs

Curing blindness with regenerative cell therapies.

Seed
16 employees
Biotechnology, Health Care

FAQ About Vetherapy® - Veterinary Regenerative Medicine

Vetherapy uses stem cells, PRP, and biomaterials to create effective veterinary regenerative medicine products.
Vetherapy® - Veterinary Regenerative Medicine was founded in 2015.
Vetherapy® - Veterinary Regenerative Medicine is headquartered in United States.
Vetherapy® - Veterinary Regenerative Medicine operates in Biotechnology. Its work centres on veterinary medicine, regenerative medicine, biotech and stem cells.
Vetherapy® - Veterinary Regenerative Medicine has approximately 2 employees.
Vetherapy® - Veterinary Regenerative Medicine has completed 2 funding rounds, raising a total of $71.43K. The latest funding stage is Grant.
Top alternatives and competitors to Vetherapy® - Veterinary Regenerative Medicine include Vetbiobank, PrimeCell Bioscience, a.s., StemSight - Vision Unlimited, PetBioCell GmbH, Synova Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vetherapy® - Veterinary Regenerative Medicine and Vetbiobank are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vetherapy® - Veterinary Regenerative Medicine, https://bouncewatch.com/company/vetherapy, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes